Longevity: To the Limits and Beyond pp 1-10 | Cite as
Practical Limits to Life Expectancy in France
Abstract
The expected duration of life for a baby born in France in 1991 was 76.9 years – 72.9 years for males and 81.2 years for females (Couet and Tambay 1995). These figure are calculated from period life tables produced from age-specific death rates that prevailed in France from 1990–1992. Estimates of the duration of life based on period life tables are predicated on the assumption that babies born in a given year will experience, for the duration of their lives, the prevailing mortality risks observed at every age. When secular declines in total mortality are occurring, as they have been in France and other developed nations for most of the 20th century, estimates of life expectancy at birth using this method tend to underestimate the subsequent longevity of the birth cohort. Given the historical trend in declining death rates in France and other developed nations, and the expectation that they will continue to decline in the future, how much higher can life expectancy at birth be expected to rise beyond these period estimates? Is the measure of period life expectancy providing a reasonable estimate of future longevity, or is it possible that the actual life expectancy of babies born in France today will be considerably higher than is currently indicated by period life tables? Alternatively, how much higher can life expectancy at birth practically increase in France and other developed nations with life expectancy (for males and females combined) approaching 80 years?
Keywords
Life Expectancy Birth Cohort Life Table High Life Expectancy Actual Life ExpectancyPreview
Unable to display preview. Download preview PDF.
References
- Ahlburg DA, Vaupel JW, (1990) Alternative projections of the U.S. population. Demography 27(4):639–652PubMedCrossRefGoogle Scholar
- Anderson KM, Castelli WP, Levy D., (1987) Cholesterol and mortality: 30 years of follow-up from the Framingham study. J Am Med Assoc 275(16):2176–2180CrossRefGoogle Scholar
- Bell FC, Wade AH, Goss SC (1993) Life tables for the United States Social Security Area 1900–2080 Actuarial study no. 107, Social Security Administration, SSA Publication No. 11–11536Google Scholar
- Bourgeois-Pichat J (1952) Essai sur la mortalité biologique de l’homme. Population 7(3):381–394CrossRefGoogle Scholar
- Bourgeois-Pichat J (1978) Future outlook for mortality decline in the world. Population Bull UN 11:12–41Google Scholar
- Carnes BA, Olshansky, SJ (1997) A biologically motivated partitioning of mortality. Experimental gerontology (in press)Google Scholar
- Carnes BA, Olshansky SJ, Grahn D (1996) Continuing the search for a law of mortality. Population Dev Rev 22(2):231–264CrossRefGoogle Scholar
- Couet C, Tambay L (1995) “La situation démographique en 1992” Insee Résultats No. 386–387Google Scholar
- Day JC (1993) Population projections of the United States, by age, sex, race, and Hispanic origin: 1992–2050. Curr Pop Rep, Series P-25, No 1092Google Scholar
- Epstein FH (1992) Low serum cholesterol, cancer and other noncardiovascular disorders. Atherosclerosis 94:1–12PubMedCrossRefGoogle Scholar
- Frick MH, Elo O, Happa K, Heinonen OP, Heinsalmi P, Helo P, Huttunen JK, Kaitaniemi P, Koskinen P, ManninenV (1987) Helsinki heart study: Primary-prevention trail with Gemfibrozil in middle- aged men with dyslipidemia. New Engl J Med 316:1237–1245CrossRefGoogle Scholar
- Fries JF (1980) Aging, natural death, and the compression of morbidity. New Engl J Med 305:130–135CrossRefGoogle Scholar
- Gardner P, Hudson BL (1996) Advance report of final mortality statistics. 1993 Monthly Vital Stat Rep 44(7-S):l–13Google Scholar
- Horiuchi S (1989) Some methodological issues in the assessment of the deceleration of the mortality decline. In: Differential mortality: methodological issues and biosocial factors. Ruzika L, Wunsch G, Kane P (eds) Oxford, Clarendon Press, pp 64–78Google Scholar
- Keyfitz N (1977) What difference would it make if cancer were eradicated? An examination of the Taeuber paradox. Demography 14:411–418PubMedCrossRefGoogle Scholar
- Keyfitz N (1985) Applied mathematical demography. 2nd ed. New York, SpringerGoogle Scholar
- Lipid Research Clinic Program (1984) Coronary primary prevention trial results: I. Reduction of incidence of coronary heart disease. J Am Med Assoc 251:351–364CrossRefGoogle Scholar
- Manton KG, Stallard E, Tolley HD., (1991) Limits to human life expectancy. Pop Devel Rev 17(4):603–637CrossRefGoogle Scholar
- Muldoon MF, Manuck SB, Matthews KA (1990) Lowering cholesterol concentrations and mortality: A quantitative review of primary prevention trials. Br Med J 301:309–314CrossRefGoogle Scholar
- Myers G, Manton K (1984)Compression of mortality: myth or reality? Gerontologist 24–346Google Scholar
- Olshansky SJ, Carnes BA (1994) Demographic perspectives on human senescence. Pop Devel Rev 20(1)57–80CrossRefGoogle Scholar
- Olshansky SJ, Carnes BA (1996) Prospect for extendend survival: a critical review of the biological evidence. In: Health and mortality among elderly populations. Caselli G, Lopez A (eds) Clarendon Press, Oxford: 39–58Google Scholar
- Olshansky SJ, Carnes BA, Cassel C (1990) In search of Methuselah: estimating the upper limits to human longevity. Science 250:634–640PubMedCrossRefGoogle Scholar
- Olshansky SJ, Rudberg MA, Carnes BA, Cassel C, Brody J (1991) Trading of longer life for worsening health: The expansion of morbidity hypothesis. J Aging Health 3(2): 194–216CrossRefGoogle Scholar
- S. J. Olshansky: Practical Limits to Life Expectancy in FranceGoogle Scholar
- Paffenbarger R, Hyde RT, Wing AL, Lee IM, Jung DL, Kampert JB (1993)The association of changes in physical-activity level and other lifestyle characteristics with mortality among men. New Engl J Med 328(8):538–545PubMedCrossRefGoogle Scholar
- Paffenbarger RS, Hyde RT, Wing AL, Hsieh C (1986) Physical activity all-cause mortality, and longevity of college alumni. New Engl J Med 314:605–613PubMedCrossRefGoogle Scholar
- Rogers RG (1995) Sociodemographic characteristics of long lived and healthy individuals. Pop Devel Rev 21(1):33–58CrossRefGoogle Scholar
- Siegel JS (1980) NIH Publ 80–969 pp 17–82Google Scholar